Receptor biology and signal transduction in pancreatic acinar cells

Current Opinion in Gastroenterology

Volumn 20, Issue 5, 2004, Pages 427-434

  Bi, Yan ^a   Williams, John A ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Acini; Ca2+; CCK receptor; Exocytosis; Pancreas; Signaling pathway

Indexed keywords

ACETYLCHOLINE DERIVATIVE; AMYLASE; CALCINEURIN; CALCIUM ION; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR; CYCLIC ADENOSINE DIPHOSPHATE RIBOSE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; PANCREAS ENZYME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RAPAMYCIN; RYANODINE RECEPTOR; SECRETIN; SYNTAXIN; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ACINAR CELL; APICAL MEMBRANE; APOPTOSIS; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL GROWTH; ENDOPLASMIC RETICULUM; EXOCYTOSIS; HOMEOSTASIS; HUMAN; INTESTINE MUCOSA; LIGAND BINDING; NONHUMAN; OLIGOMERIZATION; PANCREAS; PANCREAS SECRETION; PAROTID GLAND; PHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REVIEW; RIBOSOME; SIGNAL TRANSDUCTION; STOMACH SECRETION; STRUCTURE ACTIVITY RELATION;

EID: 4344571051     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200409000-00002     Document Type: Review

References (62)

1. Williams JA: Receptor biology and intracellular regulatory mechanisms in pancreatic acinar cells. Curr Opin Gastroenterol 2002, 18:529-535.
2. Ding XQ, Pinon DI, Furse KE, et al.: Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor. Mol Pharmacol 2002, 61:1041-1052.
3. Dawson ES, Henne RM, Miller LJ, et al.: Molecular models for cholecystokinin-A receptor. Pharmacol Toxicol 2002, 91:290-296.
4. Miller U, Lybrand TP: Molecular basis of agonist binding to the type A cholecystokinin receptor. Pharmacol Toxicol 2002, 91:282-285.
5. Harikumar KG, Pinon DI, Wessels WS, et al.: Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor. J Biol Chem 2002, 277:18552-18560.
6. Escrieut C, Gigoux V, Archer E, et al.: The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor: evidence for a crucial role of Met121 in the activation process. J Biol Chem 2002, 277:7546-7555.
7. Fourmy D, Escrieut C, Archer E, et al.: Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists. Pharmacol Toxicol 2002, 91:313-320.
8. 2+ signaling induced by CCK, ACh, and bombesin receptors on acini. Homer 2 bound to PLCβ in acini and stimulated the GAP activity of PLCβ and RGS4 in a reconstituted lysosomal system.
9. Le Page SL, Bi Y, Williams JA: CCK-A receptor activates RhoA through G alpha 12/13 in NIH3T3 cells. Am J Physiol 2003, 285:C1197-C1206.
10. Reeve JR Jr, Wu SV, Keire DA, et al.: Differential bile-pancreatic secretory effects of CCK-58 and CCK-8. Am J Physiol 2004, 286:G395-G402.
11. Reeve JR Jr, Keire DA, Coskun T, et al.: Synthesis of biologically active canine CCK-58. Regul Pept 2003, 113:71-77.
12. Cheng ZJ, Harikumar KG, Holicky EL, et al.: Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth. J Biol Chem 2003, 278:52972-52979. Demonstrates heterodimerization of type A and B CCK receptors. The heterodimeric receptor bound agonists normally but showed enhanced cellular signaling, delayed receptor internalization, and enhanced cell growth after agonist stimulation.
13. Cheng ZJ, Miller LJ: Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem 2001, 276:48040-48047.
14. Clerc P, Saillan-Barreau C, Desbois C, et al.: Transgenic mice expressing cholecystokinin 2 receptors in the pancreas. Pharmacol Toxicol 2002, 91:321-326.
15. Ding WQ, Cheng ZJ, McElhiney J, et al.: Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. Cancer Res 2002, 62:5223-5229.
16. Reubi JC, Waser B, Gugger M, et al.: Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue. Gastroenterology 2003, 125:98-106.
17. Ji B, Bi Y, Simeone D, et al.: Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 2001, 121:1380-1390.
18. Igarashi H, Ito T, Hou W, et al.: Elucidation of vasoactive intestinal peptide pharmacophore for VPAC(1) receptors in human, rat, and guinea pig. J Pharmacol Exp Ther 2002, 301:37-50.
19. Igarashi H, Ito T, Pradhan TK, et al.: Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors. J Pharmacol Exp Ther 2002, 303:445-460.
20. Xiao R, Cui ZJ: Mutual dependence of VIP/PACAP and CCK receptor signaling for a physiological role in duck exocrine pancreatic secretion. Am J Physiol 2004, 286:R189-R198.
21. Sabbatini ME, Villagra A, Davio CA, et al.: Atrial natriuretic factor stimulates exocrine pancreatic secretion in the rat through NPR-C receptors. Am J Physiol 2003, 285:G929-G937.
22. Guzman EA, Zhang W, Lin TR, et al.: Stimulation of rat pancreatic exocrine secretion by urocortin and corticotropin releasing factor. Peptides 2003, 24:727-734.
23. Kawabata A, Kuroda R, Nishida M, et al.: Protease-activated receptor-2 (PAR-2) in the pancreas and parotid gland: Immunolocalization and involvement of nitric oxide in the evoked amylase secretion. Life Sci 2002, 71:2435-2446.
24. Williams JA: Intracellular signaling mechanisms activated by cholecystokinin-regulating synthesis and secretion of digestive enzymes in pancreatic acinar cells. Annu Rev Physiol 2001, 63:77-97.
25. 2+ release channels by Gbeta-gamma. Curr Biol 2003, 13:872-876.
26. 2+-releasing messenger NAADP. Pflugers Arch 2003, 446:322-327.
27. 2+ signaling.
28. 2+ oscillations in pancreatic acinar cells. EMBO J 1994, 13:2038-2043.
29. Ashby MC, Petersen OH, Tepikin AV: Spatial characterisation of ryanodine-induced calcium release in mouse pancreatic acinar cells. Biochem J 2003, 369:441-445.
30. 2+ waves require sequential activation of inositol trisphosphate receptors and ryanodine receptors in pancreatic acini. Gastroenterology 2002, 122:415-427.
31. 3 and ryanodine receptors.
32. 2+ from a thapsigargin-sensitive store in the nuclear envelope by activating ryanodine receptors. J Cell Biol 2003, 163:271-282.
33. 2+ signaling using CD38 knockout mice. J Biol Chem 2001, 276:649-655.
34. Sternfeld L, Krause E, Guse AH, et al.: Hormonal control of ADP-ribosyl cyclase activity in pancreatic acinar cells from rats. J Biol Chem 2003, 278:3629-3636.
35. Straub SV, Giovannucci DR, Bruce JI, et al.: A role for phosphorylation of inositol 1,4,5-trisphosphate receptors in defining calcium signals induced by peptide agonists in pancreatic acinar cells. J Biol Chem 2002, 277:31949-31956.
36. Gerasimenko OV, Gerasimenko JV, Rizzuto RR, et al.: The distribution of the endoplasmic reticulum in living pancreatic acinar cells. Cell Calcium 2002, 32:261-268.
37. 3 and cADP-ribose, whereas lysosomal-related organelles were selected by NAADP.
38. 2+ homeostasis of mouse pancreatic acinar cells. Cell Calcium 2002, 32:59-69.
39. Gonzalez A, Granados MP, Salido GM, et al.: Changes in mitochondrial activity evoked by cholecystokinin in isolated mouse pancreatic acinar cells. Cell Signal 2003, 15:1039-1048.
40. 2+ leak from the endoplasmic reticulum of pancreatic acinar cells: second messenger-activated channels and translocons. J Biol Chem 2002, 277:26479-26485.
41. 2+ release sites.
42. Park MK, Lee M, Petersen OH: Morphological and functional changes of dissociated single pancreatic acinar cells: testing the suitability of the single cell as a model for exocytosis and calcium signaling. Cell Calcium 2004, 35:367-379.
43. 2+ entry and exit pathways in exocrine gland cells. Cell Calcium 2003, 33:337-344.
44. Chen X, Edwards JA, Logsdon CD, et al.: Dominant negative Rab3D inhibits amylase release from mouse pancreatic acini. J Biol Chem 2002, 277:18002-18009.
45. Chen X, Ernst SA, Williams JA: Dominant negative Rab3D mutants reduce GTP-bound endogenous Rab3D in pancreatic acini. J Biol Chem 2003, 278:50053-50060. Secretion by acinar cells was shown to require GTP-liganded Rab3D on zymogen granules. Inhibition by dominant-negative mutants affected GTP loading and not the targeting of Rab3D to the granules.
46. Riedel D, Antonin W, Fernandez-Chacon R, et al.: Rab3D is not required for exocrine exocytosis but for maintenance of normally sized secretory granules. Mol Cell Biol 2002, 22:6487-6497.
47. Antonin W, Wagner M, Riedel D, et al.: Loss of the zymogen granule protein syncollin affects pancreatic protein synthesis and transport but not secretion. Mol Cell Biol 2002, 22:1545-1554.
48. Geisse NA, Wasle B, Saslowsky DE, et al.: Syncollin homo-oligomers associate with lipid bilayers in the form of doughnut-shaped structures. J Membr Biol 2002, 189:83-92.
49. 2+-sensitive CRHSP-28-binding protein in pancreatic acinar cells. J Biol Chem 2002, 277:35496-35502.
50. Kaspar KM, Thomas DD, Weng N, et al.: Dietary and hormonal stimulation of rat exocrine pancreatic function regulates CRHSP-28 phosphorylation in vivo. J Nutr 2003, 133:3072-3075.
51. Sans MD, Williams JA: Translational control of protein synthesis in pancreatic acinar cells. Int J Gastrointest Cancer 2002, 31:107-115.
52. Sans MD, Williams JA: Calcineurin is required for translational control of protein synthesis in rat pancreatic acini. Am J Physiol 2004, in press.
53. Tashiro M, Samuelson LC, Liddle RA, et al.: Calcineurin mediates pancreatic growth in protease inhibitor-treated mice. Am J Physiol 2004, 286:G784-G790. Pancreatic growth in response to feeding the serine protease inhibitor camostat was shown to require CCK. Moreover, growth was accompanied by upregulation of calcineurin and could be blocked with two inhibitors of calcineurin, cyclosporin A and FK506, thereby implicating a requirement for calcineurin in the growth response.
54. Jia DM, Otsuki M: Troglitazone stimulates pancreatic growth in normal rats. Pancreas 2002, 24:303-312.
55. Gukovskaya AS, Cheng JH, Nam KJ, et al.: Phosphatidylinositide 3-kinase γ regulates key pathologic response to cholecystokinin in pancreatic acinar cells. Gastroenterology 2004, 126:554-566.
56. Tapia JA, Garcia-Marin LJ, Jensen RT: Cholecystokinin-stimulated protein kinase C-delta kinase activation, tyrosine phosphorylation, and translocation are mediated by Src tyrosine kinases in pancreatic acinar cells. J Biol Chem 2003, 278:35220-35230. Cholecystokinin was shown to stimulate PKCδ tyrosine phosphorylation, whereas PKCδ kinase activity could be blocked by Src kinase inhibitors. The results indicate the involvement of Src in PKCδ phosphorylation and activation.
57. Andreolotti AG, Bragado MJ, Tapia JA, et al.: Cholecystokinin rapidly stimulates CrkII function in vivo in rat pancreatic acini: formation of CrkII-protein complexes. Eur J Biochem 2003, 270:4706-4713.
58. Piiper A, Elez R, You SJ, et al.: Cholecystokinin stimulates extracellular signal regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C: signal amplification at the level of Raf by activation of protein kinase C epsilon. J Biol Chem 2003, 278:7065-7072. A study in AR42J cells showed that three different signaling pathways from the CCKAR mediate ERK activation: transactivation of EGFR and activation of Yes mediate Shc-Grb2 recruitment, and activation of PKCε augments CCK-stimulated ERK activation at the Ras/Raf level.
59. Pace A, Garcia-Marin LJ, Tapia JA, et al.: Phosphospecific site tyrosine phosphorylation of p125FAK and proline-rich kinase 2 is differentially regulated by cholecystokinin receptor type A activation in pancreatic acini. J Biol Chem 2003, 278:19008-19016.
60. Aparicio IM, Garcia-Marin LJ, Andreolotti AG, et al.: Hepatocyte growth factor activates several transduction pathways in rat pancreatic acini. Biochim Biophys Acta 2003, 1643:37-46.
61. DiMagno MJ, Hao Y, Tsunoda Y, et al.: Secretagogue-stimulated pancreatic secretion is differentially regulated by constitutive NOS isoforms in mice. Am J Physiol 2004, 286:G428-G436.
62. Trulsson LM, Gasslander T, Sundqvist T, et al.: The influence of nitric oxide on basal and cholecystokinin-8-induced proliferation and apoptosis in the rat pancreas. Regul Pept 2002, 106:97-104.